UBS Group AG - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 92 filers reported holding EIDOS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 3.15 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$23,000
+2200.0%
171
+968.8%
0.00%
Q3 2020$1,000
-93.8%
16
-95.2%
0.00%
Q2 2020$16,000
-90.0%
332
-89.8%
0.00%
Q1 2020$160,000
-76.0%
3,261
-72.0%
0.00%
Q4 2019$668,000
+2054.8%
11,642
+1252.1%
0.00%
Q3 2019$31,000
-24.4%
861
-35.6%
0.00%
Q2 2019$41,000
+925.0%
1,336
+724.7%
0.00%
Q1 2019$4,000
-60.0%
162
-78.0%
0.00%
Q4 2018$10,000
-41.2%
735
-56.9%
0.00%
Q3 2018$17,000
-46.9%
1,707
+7.6%
0.00%
Q2 2018$32,0001,5860.00%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$56,777,00018.14%
Board of Trustees of The Leland Stanford Junior University 265,670$13,425,0005.17%
Opaleye Management Inc. 315,550$15,945,0003.12%
RA Capital Management 2,163,271$109,310,0002.00%
Cormorant Asset Management, LP 993,185$50,186,0001.93%
Parkman Healthcare Partners LLC 41,091$2,076,0000.55%
Perceptive Advisors 686,922$34,710,0000.51%
Redmile Group, LLC 466,205$23,557,0000.43%
Eventide Asset Management 317,417$16,039,0000.31%
Ikarian Capital, LLC 63,011$3,184,0000.23%
View complete list of EIDOS THERAPEUTICS INC shareholders